1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Fosaprepitant 150 mg: new trials by email Literature Review of Fosaprepitant 150 mg trials Research Report on Fosaprepitant 150 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183) Fosaprepitant 150 mg, Aprepitant 165 mg, Aprepitant 250 mg - Chemotherapy-Induced Nausea and Vomiting (CINV) | Phase 1 | Completed | Merck Sharp & Dohme LLC | 16 | 2010-04-01 | 2015-02-25 |
Vomiting (1)